Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Quest Diagnostics' stock soars as major firms invest, earnings beat estimates, and dividend rises.
Quest Diagnostics, a medical testing company, saw its stock holdings rise significantly in the fourth quarter as several firms increased their investments.
Riverwater Partners LLC now owns 10,358 shares, valued at $1.56 million, while Landscape Capital Management L.L.C.
owns 12,969 shares, valued at $1.96 million.
The company's earnings per share for the quarter were $2.23, beating estimates.
Quest Diagnostics also increased its quarterly dividend by 6.7% to $0.80 per share, with a yield of 1.95%.
Analysts expect the company to post 9.7 EPS for the current fiscal year.
9 Articles
Las acciones de Quest Diagnostics se elevan a medida que las principales empresas invierten, las ganancias superan las estimaciones y los dividendos aumentan.